Overhyped or Ready for Primetime: Is There a Predictive Role for MRD in Early-Stage Colorectal Cancer - Live

April 21, 2026

Webinar Description

As ctDNA technology rapidly evolves, clinicians face the challenge of integrating these assays into standard oncologic applications and limitations of current testing.

Learning Objectives

  • Describe the methodologies for testing circulating tumor DNA
  • Describe the observational and prospective clinical trial data with ctDNA and early-stage colorectal cancer
  • Current implementation strategies for ctDNA in clinical practice

 

Flyers

Share the flyer and/or this webpage:

Webinar Registration


Access WebEx

Attending the Webinar

Claiming Credit

  • Click on the button "Take Course" and claim CME credit, ABIM MOC Part 2 credit, or participation certificate.

Instructions

See our FAQ for more information on creating and account, attending an event, and claiming credit.

Contact us with any questions at [email protected] or (919) 445–1000.

 

Course summary
Available credit: 
  • 1.00 ABIM Medical Knowledge
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
01/16/2026
Course expires: 
04/28/2026
Event starts: 
04/21/2026 - 4:00pm EDT
Event ends: 
04/21/2026 - 5:00pm EDT
Cancer Grand Rounds Logo 

The Lineberger Cancer Center Grand Rounds are educational activities regarding cancer. We cover the most relevant oncology topics.

These webinars provide FREE continuing education credit.

UNC Lineberger Cancer Grand Rounds are presented as a hybrid event with in-person and online viewing options. 

Image of peopleORImage of webinar icon
In-person at:
Conference Room 1 at the N.C. Basnight Cancer Hospital
 


Online via Zoom:
Link will be provided in confirmation email

 

Photo of Chris Lieu, MD 

Chris Lieu, MD

Professor
Medicine-Medical Oncology
University of Colorado

Disclosures

Activity Planners
This activity has been planned and implemented under the sole supervision of the Course Directors, Jared Weiss, MD; Deborah Marie Stephens, DO; and Kaitlin Morrison, PhD, of the UNC School of Medicine in association with the UNC Office of Continuing Professional Development (CPD). Dr. Weiss is a stockholder in Vesselon, Nuvalent, En Fuego Therapeutics, Vertex, Merus, Revmed; receives consulting fees from AZ, EMD Serono, Nanobiotix, PDS, Amgen, Pharmacosmos, GSK; and receives research grants from Pharmacosmos, Loxo, PDS, Genmab, Iovance, Nurix, TSCAN, Janus, BMS, Summit. These financial relationships have been mitigated. Dr. Stephens has served on advisory boards for Abbvie, AstraZeneca, BeOne, BMS, Genentech, Pfizer, Pharmacyclics, J&J. These were one time consulting efforts, but she is asked periodically to serve on additional boards. She is a consultant for Abbvie and this is an ongoing relationship. She has also received research grants research grants to Lineberger Comprehensive Cancer Center from BeOne, which are ongoing. Dr. Morrison has no relevant financial relationships with ineligible companies as defined by the ACCME. CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME. The planning committee members and their relevant financial relationships with ineligible companies as defined by the ACCME can be found at https://learn.unclcn.org/content/lineberger-cancer-center-grand-rounds-planning-committee.

Speaker
The presenter has no relevant financial relationships with ineligible companies as defined by the ACCME.

 

Accreditation Statements

1.00 ABIM MOC Part 2 Credit
CME MOC ABIM badge
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Part 2 credit.

1.00 AMA PRA Category 1 Credit™
The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The School of Medicine of the University of North Carolina at Chapel Hill designates this live internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Notice

Attendees are required to view a minimum of 53 minutes of the live webinar video to receive CME credit.

Available Credit

  • 1.00 ABIM Medical Knowledge
  • 1.00 AMA PRA Category 1 Credit
Please login or register to take this course.